http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0027804-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e29e8934838be2b5bd2772f4038fca6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a39e9717f56322318e4ddb037a59ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d2a0b887515bc238d55b4233c668ff3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5d79504afcf76c9dfa15825a758e572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7909ed3cf82f0dfdd4dd6cb69f1c4f15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_559ec3960c545c6b9f01db728ad39dba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c77d885e071e40bcb26714d0250c0bd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-22
filingDate 1999-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fef58c972f3b2361eacf76eedc535bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36d688572890b5a4d50164987b2a4347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf3c5605941aba95d223c6f9f4ca3d0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e45e1d46ae8869e260ae112f017dd978
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_432adf63ee93914b9e99cf52669ee7a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7df2607373837128cdbf015b473c8fd
publicationDate 2000-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0027804-A1
titleOfInvention Method for the crystallization of iopamidol
abstract Disclosed is the crystallization of Iopamidol using a mixture of an alcohol and water as a crystallization solvent. The ratios of water:Iopamidol from 1:10 to 1:1 (v/w) and alcohol:Iopamidol from 1:1 to 1:10 (v/w) allow Iopamidol to be crystallized to an anhydrous pure form with industrially valuable yields without producing monohydrates and pentahydrates.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007073202-A1
priorityDate 1998-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5571941-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5689002-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0747344-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9834908-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728521

Total number of triples: 34.